Advertisement

Phospho-substrate profiling of Epac-dependent protein kinase C activity

  • Diana J. Goode
  • Derek C. MolliverEmail author
Article
  • 12 Downloads

Abstract

Exchange protein directly activated by cAMP (Epac) and protein kinase A are effectors for cAMP with distinct actions and regulatory mechanisms. Epac is a Rap guanine nucleotide exchange factor that activates Rap1; protein kinase C (PKC) is a major downstream target of Epac-Rap1 signaling that has been implicated in a variety of pathophysiological processes, including cardiac hypertrophy, cancer, and nociceptor sensitization leading to chronic pain. Despite the implication of both Epac and PKC in these processes, few downstream targets of Epac-PKC signaling have been identified. This study characterized the regulation of PKC activity downstream of Epac activation. Using an antibody that recognizes phospho-serine residues within the consensus sequence phosphorylated by PKC, we analyzed the 1-dimensional banding profile of PKC substrate protein phosphorylation from the Neuro2A mouse neuroblastoma cell line. Activation of Epac either indirectly by prostaglandin PGE2, or directly by 8-pCPT-2-O-Me-cAMP-AM (8pCpt), produced distinct PKC phospho-substrate protein bands that were suppressed by co-administration of the Epac inhibitor ESI09. Different PKC isoforms contributed to the induction of individual phospho-substrate bands, as determined using isoform-selective PKC inhibitors. Moreover, the banding profile after Epac activation was altered by disruption of the cytoskeleton, suggesting that the orchestration of Epac-dependent PKC signaling is regulated in part by interactions with the cytoskeleton. The approach described here provides an effective means to characterize Epac-dependent PKC activity.

Keywords

Signal transduction Phosphorylation Prostaglandins Cytoskeleton 

Notes

Acknowledgements

All work reported here was funded by the National Institutes of Health Institute of General Medical Sciences, Grants RO1102346 and P20GM103643.

Compliance with ethical standards

Conflict of interest

All authors certify that they have no conflicts of interest.

Ethical approval

This article does not contain any studies with animals performed by any of the authors. This article does not contain any studies with human participants performed by any of the authors.

References

  1. 1.
    Sunahara RK, Dessauer CW, Gilman AG (1996) Complexity and diversity of mammalian adenylyl cyclases. Annu Rev Pharmacol Toxicol 36:461–480.  https://doi.org/10.1146/annurev.pa.36.040196.002333 CrossRefGoogle Scholar
  2. 2.
    Walsh DA, Perkins JP, Krebs EG (1968) An adenosine 3′,5′-monophosphate-dependant protein kinase from rabbit skeletal muscle. J Biol Chem 243:3763–3765Google Scholar
  3. 3.
    Dhallan RS, Yau K-W, Schrader KA, Reed RR (1990) Primary structure and functional expression of a cyclic nucleotide-activated channel from olfactory neurons. Nature 347:184CrossRefGoogle Scholar
  4. 4.
    de Rooij J, Zwartkruis FJ, Verheijen MH et al (1998) Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396:474–477.  https://doi.org/10.1038/24884 CrossRefGoogle Scholar
  5. 5.
    Kawasaki H, Springett GM, Mochizuki N et al (1998) A family of cAMP-binding proteins that directly activate Rap1. Science 282:2275–2279CrossRefGoogle Scholar
  6. 6.
    Kwan EP, Gao X, Leung YM, Gaisano HY (2007) Activation of exchange protein directly activated by cyclic adenosine monophosphate and protein kinase A regulate common and distinct steps in promoting plasma membrane exocytic and granule-to-granule fusions in rat islet beta cells. Pancreas 35:e45–e54.  https://doi.org/10.1097/mpa.0b013e318073d1c9 CrossRefGoogle Scholar
  7. 7.
    Bacallao K, Monje PV (2013) Opposing roles of pka and epac in the cAMP-dependent regulation of Schwann Cell Proliferation and Differentiation. PLoS ONE 8:e82354.  https://doi.org/10.1371/journal.pone.0082354 CrossRefGoogle Scholar
  8. 8.
    Scott J, Harris GJ, Pinder EM et al (2016) Exchange protein directly activated by cyclic AMP (EPAC) activation reverses neutrophil dysfunction induced by beta2-agonists, corticosteroids, and critical illness. J Allergy Clin Immunol 137:535–544.  https://doi.org/10.1016/j.jaci.2015.07.036 CrossRefGoogle Scholar
  9. 9.
    Hucho TB, Dina OA, Levine JD (2005) Epac mediates a cAMP-to-PKC signaling in inflammatory pain: an isolectin B4(+) neuron-specific mechanism. J Neurosci 25:6119–6126.  https://doi.org/10.1523/JNEUROSCI.0285-05.2005 CrossRefGoogle Scholar
  10. 10.
    Cazorla O, Lucas A, Poirier F et al (2009) The cAMP binding protein Epac regulates cardiac myofilament function. Proc Natl Acad Sci USA 106:14144.  https://doi.org/10.1073/pnas.0812536106 CrossRefGoogle Scholar
  11. 11.
    Schmidt M, Evellin S, Weernink PA et al (2001) A new phospholipase-C-calcium signalling pathway mediated by cyclic AMP and a Rap GTPase. Nat Cell Biol 3:1020–1024.  https://doi.org/10.1038/ncb1101-1020 CrossRefGoogle Scholar
  12. 12.
    Berridge MJ (1993) Inositol trisphosphate and calcium signalling. Nature 361:315–325.  https://doi.org/10.1038/361315a0 CrossRefGoogle Scholar
  13. 13.
    Medkova M, Cho W (1999) Interplay of C1 and C2 domains of protein kinase C-α in its membrane binding and activation. J Biol Chem 274:19852–19861.  https://doi.org/10.1074/jbc.274.28.19852 CrossRefGoogle Scholar
  14. 14.
    Dries DR, Gallegos LL, Newton AC (2007) A single residue in the C1 domain sensitizes novel protein kinase C isoforms to cellular diacylglycerol production. J Biol Chem 282:826–830.  https://doi.org/10.1074/jbc.C600268200 CrossRefGoogle Scholar
  15. 15.
    Stone LS, Molliver DC (2009) In search of analgesia: emerging roles of GPCRs in pain. Mol Interv 9:234–251.  https://doi.org/10.1124/mi.9.5.7 CrossRefGoogle Scholar
  16. 16.
    Singhmar P, Huo X, Eijkelkamp N et al (2016) Critical role for Epac1 in inflammatory pain controlled by GRK2-mediated phosphorylation of Epac1. Proc Natl Acad Sci USA 113:3036–3041.  https://doi.org/10.1073/pnas.1516036113 CrossRefGoogle Scholar
  17. 17.
    Almahariq M, Tsalkova T, Mei FC et al (2013) A novel EPAC-specific inhibitor suppresses pancreatic cancer cell migration and invasion. Mol Pharmacol 83:122–128.  https://doi.org/10.1124/mol.112.080689 CrossRefGoogle Scholar
  18. 18.
    Molliver DC, Lindsay J, Albers KM, Davis BM (2005) Overexpression of NGF or GDNF alters transcriptional plasticity evoked by inflammation. Pain 113:277–284.  https://doi.org/10.1016/j.pain.2004.10.025 CrossRefGoogle Scholar
  19. 19.
    Mo C, Zhao R, Vallejo J et al (2015) Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation. Cell Cycle 14:1507–1516.  https://doi.org/10.1080/15384101.2015.1026520 CrossRefGoogle Scholar
  20. 20.
    Aked DM, Foster SJ (1987) Leukotriene B4 and prostaglandin E2 mediate the inflammatory response of rabbit skin to intradermal arachidonic acid. Br J Pharmacol 92:545–552CrossRefGoogle Scholar
  21. 21.
    Dayer JM, Goldring SR, Robinson DR, Krane SM (1979) Collagenase and prostaglandin in connective tissue destruction: cell–cell and humoral interactions. Bull Schweiz Akad Med Wiss 35:329–343Google Scholar
  22. 22.
    Sugimoto Y, Narumiya S (2007) Prostaglandin E receptors. J Biol Chem 282:11613–11617.  https://doi.org/10.1074/jbc.R600038200 CrossRefGoogle Scholar
  23. 23.
    Nishikawa K, Toker A, Johannes FJ et al (1997) Determination of the specific substrate sequence motifs of protein kinase C isozymes. J Biol Chem 272:952–960CrossRefGoogle Scholar
  24. 24.
    Borland G, Bird RJ, Palmer TM, Yarwood SJ (2009) Activation of protein kinase Calpha by EPAC1 is required for the ERK- and CCAAT/enhancer-binding protein beta-dependent induction of the SOCS-3 gene by cyclic AMP in COS1 cells. J Biol Chem 284:17391–17403.  https://doi.org/10.1074/jbc.M109.015370 CrossRefGoogle Scholar
  25. 25.
    Gu Y, Li G, Chen Y, Huang L-YM (2016) Epac-PKCalpha signaling in purinergic P2 × 3R-mediated hyperalgesia after inflammation. Pain 157:1541–1550.  https://doi.org/10.1097/j.pain.0000000000000547 CrossRefGoogle Scholar
  26. 26.
    Mei FC, Cheng X (2005) Interplay between exchange protein directly activated by cAMP (Epac) and microtubule cytoskeleton. Mol Biosyst 1:325–331.  https://doi.org/10.1039/b511267b CrossRefGoogle Scholar
  27. 27.
    Dina OA, McCarter GC, de Coupade C, Levine JD (2003) Role of the sensory neuron cytoskeleton in second messenger signaling for inflammatory pain. Neuron 39:613–624.  https://doi.org/10.1016/S0896-6273(03)00473-2 CrossRefGoogle Scholar
  28. 28.
    Maekawa M, Ishizaki T, Boku S et al (1999) Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and. Science 285:895–898CrossRefGoogle Scholar
  29. 29.
    Ohashi K, Nagata K, Maekawa M et al (2000) Rho-associated kinase ROCK activates LIM-kinase 1 by phosphorylation at threonine 508 within the activation loop. J Biol Chem 275:3577–3582CrossRefGoogle Scholar
  30. 30.
    Leung T, Chen XQ, Manser E, Lim L (1996) The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol Cell Biol 16:5313–5327CrossRefGoogle Scholar
  31. 31.
    Matsui T, Yonemura S, Tsukita S, Tsukita S (1999) Activation of ERM proteins in vivo by Rho involves phosphatidyl-inositol 4-phosphate 5-kinase and not ROCK kinases. Curr Biol 9:1253–1259.  https://doi.org/10.1016/S0960-9822(99)80508-9 CrossRefGoogle Scholar
  32. 32.
    Arpin M, Chirivino D, Naba A, Zwaenepoel I (2011) Emerging role for ERM proteins in cell adhesion and migration. Cell Adh Migr 5:199–206.  https://doi.org/10.4161/cam.5.2.15081 CrossRefGoogle Scholar
  33. 33.
    Lin JJ, Chou CS, Lin JL (1985) Monoclonal antibodies against chicken tropomyosin isoforms: production, characterization, and application. Hybridoma 4:223–242.  https://doi.org/10.1089/hyb.1985.4.223 CrossRefGoogle Scholar
  34. 34.
    Broschat KO, Weber A, Burgess DR (1989) Tropomyosin stabilizes the pointed end of actin filaments by slowing depolymerization. Biochemistry 28:8501–8506.  https://doi.org/10.1021/bi00447a035 CrossRefGoogle Scholar
  35. 35.
    Fowler VM, Bennett V (1984) Erythrocyte membrane tropomyosin. Purification and properties. J Biol Chem 259:5978–5989Google Scholar
  36. 36.
    Somara S, Pang H, Bitar KN (2005) Agonist-induced association of tropomyosin with protein kinase Calpha in colonic smooth muscle. Am J Physiol Gastrointest Liver Physiol 288:G268–G276.  https://doi.org/10.1152/ajpgi.00330.2004 CrossRefGoogle Scholar
  37. 37.
    Wu D, Katz A, Lee CH, Simon MI (1992) Activation of phospholipase C by alpha 1-adrenergic receptors is mediated by the alpha subunits of Gq family. J Biol Chem 267:25798–25802Google Scholar
  38. 38.
    Ghazi H, Osborne NN (1988) Activation of phosphoinositide-specific PLC increase free intracellular calcium in rabbit retinal cultures. Neurochem Int 13:397–403CrossRefGoogle Scholar
  39. 39.
    Gray PC, Scott JD, Catterall WA (1998) Regulation of ion channels by cAMP-dependent protein kinase and A-kinase anchoring proteins. Curr Opin Neurobiol 8:330–334.  https://doi.org/10.1016/S0959-4388(98)80057-3 CrossRefGoogle Scholar
  40. 40.
    Niimura M, Miki T, Shibasaki T et al (2009) Critical role of the N-terminal cyclic AMP-binding domain of Epac2 in its subcellular localization and function. J Cell Physiol 219:652–658.  https://doi.org/10.1002/jcp.21709 CrossRefGoogle Scholar
  41. 41.
    Parnell E, Palmer TM, Yarwood SJ (2015) The future of EPAC-targeted therapies: agonism versus antagonism. Trends Pharmacol Sci 36:203–214.  https://doi.org/10.1016/j.tips.2015.02.003 CrossRefGoogle Scholar
  42. 42.
    Kumar N, Prasad P, Jash E et al (2018) Insights into exchange factor directly activated by cAMP (EPAC) as potential target for cancer treatment. Mol Cell Biochem 447:77–92.  https://doi.org/10.1007/s11010-018-3294-z CrossRefGoogle Scholar
  43. 43.
    Hong K, Lou L, Gupta S et al (2008) A novel Epac-Rap-PP2A signaling module controls cAMP-dependent Akt regulation. J Biol Chem 283:23129–23138.  https://doi.org/10.1074/jbc.M800478200 CrossRefGoogle Scholar
  44. 44.
    Li L, Cai H, Liu H, Guo T (2015) β-Adrenergic stimulation activates protein kinase Cε and induces extracellular signal-regulated kinase phosphorylation and cardiomyocyte hypertrophy. Mol Med Rep 11:4373–4380.  https://doi.org/10.3892/mmr.2015.3316 CrossRefGoogle Scholar
  45. 45.
    Collazos A, Diouf B, Guérineau NC et al (2006) A Spatiotemporally coordinated cascade of protein kinase C activation controls isoform-selective translocation. Mol Cell Biol 26:2247–2261.  https://doi.org/10.1128/MCB.26.6.2247-2261.2006 CrossRefGoogle Scholar
  46. 46.
    Almahariq M, Mei FC, Cheng X (2014) cAMP sensor EPAC proteins and energy homeostasis. Trends Endocrinol Metab 25:60–71.  https://doi.org/10.1016/j.tem.2013.10.004 CrossRefGoogle Scholar
  47. 47.
    Sehrawat S, Cullere X, Patel S et al (2008) Role of Epac1, an exchange factor for Rap GTPases, in endothelial microtubule dynamics and barrier function. Mol Biol Cell 19:1261–1270.  https://doi.org/10.1091/mbc.E06-10-0972 CrossRefGoogle Scholar
  48. 48.
    Cullere X, Shaw SK, Andersson L et al (2005) Regulation of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap GTPase. Blood 105:1950–1955.  https://doi.org/10.1182/blood-2004-05-1987 CrossRefGoogle Scholar
  49. 49.
    Jeyaraj SC, Unger NT, Eid AH et al (2012) Cyclic AMP-Rap1A signaling activates RhoA to induce α(2c)-adrenoceptor translocation to the cell surface of microvascular smooth muscle cells. Am J Physiol Cell Physiol 303:C499–C511.  https://doi.org/10.1152/ajpcell.00461.2011 CrossRefGoogle Scholar
  50. 50.
    Gloerich M, Ponsioen B, Vliem MJ et al (2010) Spatial regulation of cyclic AMP-Epac1 signaling in cell adhesion by ERM proteins. Mol Cell Biol 30:5421–5431.  https://doi.org/10.1128/MCB.00463-10 CrossRefGoogle Scholar
  51. 51.
    Ponsioen B, Gloerich M, Ritsma L et al (2009) Direct spatial control of Epac1 by cyclic AMP. Mol Cell Biol 29:2521–2531.  https://doi.org/10.1128/MCB.01630-08 CrossRefGoogle Scholar
  52. 52.
    Bernstein BW, Bamburg JR (1982) Tropomyosin binding to F-actin protects the F-actin from disassembly by brain actin-depolymerizing factor (ADF). Cell Motil 2:1–8CrossRefGoogle Scholar
  53. 53.
    Tigges U, Koch B, Wissing J et al (2003) The F-actin cross-linking and focal adhesion protein filamin A is a ligand and in vivo substrate for protein kinase C alpha. J Biol Chem 278:23561–23569.  https://doi.org/10.1074/jbc.M302302200 CrossRefGoogle Scholar
  54. 54.
    Hui X, Sauer B, Kaestner L et al (2017) PKCα diffusion and translocation are independent of an intact cytoskeleton. Sci Rep 7:475.  https://doi.org/10.1038/s41598-017-00560-7 CrossRefGoogle Scholar
  55. 55.
    McConnachie G, Langeberg LK, Scott JD (2006) AKAP signaling complexes: getting to the heart of the matter. Trends Mol Med 12:317–323.  https://doi.org/10.1016/j.molmed.2006.05.008 CrossRefGoogle Scholar
  56. 56.
    Munoz-Llancao P, de Gregorio C, Las Heras M et al (2017) Microtubule-regulating proteins and cAMP-dependent signaling in neuroblastoma differentiation. Cytoskeleton (Hoboken) 74:143–158.  https://doi.org/10.1002/cm.21355 CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Biomedical SciencesUniversity of New EnglandBiddefordUSA

Personalised recommendations